- Home
- MRVI vs BWMX Comparison
MRVI vs BWMX Comparison
Compare MRVI & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- BWMX
- Stock Information
- Founded
- MRVI 2014
- BWMX 1995
- Country
- MRVI United States
- BWMX Mexico
- Employees
- MRVI N/A
- BWMX N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- BWMX Catalog/Specialty Distribution
- Sector
- MRVI Health Care
- BWMX Consumer Discretionary
- Exchange
- MRVI Nasdaq
- BWMX Nasdaq
- Market Cap
- MRVI 312.4M
- BWMX 354.5M
- IPO Year
- MRVI 2020
- BWMX N/A
- Fundamental
- Price
- MRVI $2.22
- BWMX $7.78
- Analyst Decision
- MRVI Hold
- BWMX Strong Buy
- Analyst Count
- MRVI 10
- BWMX 1
- Target Price
- MRVI $6.84
- BWMX $22.50
- AVG Volume (30 Days)
- MRVI 1.9M
- BWMX 63.2K
- Earning Date
- MRVI 05-12-2025
- BWMX 07-24-2025
- Dividend Yield
- MRVI N/A
- BWMX 16.27%
- EPS Growth
- MRVI N/A
- BWMX N/A
- EPS
- MRVI N/A
- BWMX 0.74
- Revenue
- MRVI $241,856,000.00
- BWMX $684,841,453.00
- Revenue This Year
- MRVI N/A
- BWMX $4.90
- Revenue Next Year
- MRVI $10.73
- BWMX $6.07
- P/E Ratio
- MRVI N/A
- BWMX $10.31
- Revenue Growth
- MRVI N/A
- BWMX 4.87
- 52 Week Low
- MRVI $1.67
- BWMX $7.00
- 52 Week High
- MRVI $10.03
- BWMX $17.50
- Technical
- Relative Strength Index (RSI)
- MRVI 52.01
- BWMX 24.27
- Support Level
- MRVI $2.20
- BWMX $7.40
- Resistance Level
- MRVI $2.41
- BWMX $8.90
- Average True Range (ATR)
- MRVI 0.15
- BWMX 0.56
- MACD
- MRVI 0.01
- BWMX -0.12
- Stochastic Oscillator
- MRVI 58.06
- BWMX 27.37
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.